| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -611 | -853 |
| Effect of exchange rate change on cash and cash equivalents | 656 | -114 |
| Net (decrease) increase in cash and cash equivalents | -20,035 | -13,169 |
| Cash and cash equivalents at end of period | 63,567 | - |
PALVELLA THERAPEUTICS, INC. (PVLA)
PALVELLA THERAPEUTICS, INC. (PVLA)